Rebecca Auer

Researcher
  • Ottawa Hospital Research Institute
  • University of Ottawa
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Completed
    All Cancers

    Canadian Oncolytic Virus Consortium (COVCo)

    In a perfect world, there would be no cancer. And if there were, patients would be able to stimulate their own immune system to destroy tumours with a virus designed to kill only cancerous cells and l...

    Read More
  • Completed
    Melanoma

    A personalized oncolytic vaccine: using oncolytic viruses to exploit neo-antigens derived from the tumour mutanome

    Dr. Auer, a surgical oncologist at the Ottawa Hospital and University of Ottawa assistant professor, is developing a personalized vaccine that is combined with a cancerfighting virus. The immune syste...

    Read More

Related News & Events

  • Research Highlight|May 17, 2018

    Erectile dysfunction drugs and flu vaccine may work together to help immune system fight cancer after surgery, study finds

    A new study led by Dr. Rebecca Auer, a member of TFRI's Oncolytic Virus project and former recipient of a TFRI New Investigator Award, suggests that a...

  • Research Highlight|September 06, 2017

    Vaccine shows promise in models, eradicates intra-abdominal tumours in over 90 per cent of mice

    Ontario cancer researchers have found that an oncolytic virus may lead to a promising new therapy option for patients with peritoneal carcinomatosis, ...

  • Research Highlight|May 24, 2017

    Complement inhibitors decrease neutralization of some oncolytic viruses, increase treatment efficacy

    The use of oncolytic viruses to stimulate a patient’s immune system as well as directly kill tumour cells is a novel approach to eradicating cancer, b...

  • All News & Events